Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA

Clinical trial NCT00730249 · COMPLETED

Trial details

NCT number: NCT00730249
Sponsor: Medice Arzneimittel Pütter GmbH & Co KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2008-09-01
Primary completion: 2010-01-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.